Oligodeoxyribonucleotides (ODNs) with conjugated reactive groups
are potential sequence-specific gene
inactivating agents. The antitumor antibiotic CC-1065 binds
preferably in the minor groove of A-T-rich sites of
double-stranded DNA, and the cyclopropapyrroloindole (CPI) subunit of
the drug alkylates adenines at their N3
position. Pure enantiomeric (+)- and (−)-CPI and its N5-methyl
homologue (MCPI) were synthesized and conjugated
to an ODN. These conjugates were evaluated for their ability to
alkylate a target containing a duplex region
immediately adjacent to a single-stranded complementary binding region
for the ODN conjugate. The conjugates
demonstrated excellent stability in physiologic conditions and
stereospecific, hybridization-triggered alkylation of
the synthetic ODN targets. The dependence of the reaction rates on
sequence of the duplex target region was in
accord with the predicted minor groove binding of the conjugated CPI.
The reactivity was highly dependent on the
structure of the cross-linking group. Natural (+)-enantiomers
alkylate 10−20 times faster than the corresponding
(−)-enantiomers. Regiospecificity of the alkylation reaction is
conferred by the length of the spacer arm. N5-Methylation of the CPI moiety suppresses the reactivity by a factor of
3−5. Addition of a
1,2-dihydro-3H-pyrrolo[3,2-e]indole-7-carboxylate (DPI) binding subunit of
CC-1065 between CPI or MCPI residues and an ODN results
in a significant enhancement of the reactivity which is especially
pronounced for (−)-enantiomers. The main products
of sequence-specific alkylation were determined for complexes with the
most efficient reactions.